Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention.
<label>BACKGROUND</label>Breast cancer can be prevented with selective estrogen receptor modifiers (SERMs) and aromatase inhibitors (AIs). The US Preventive Services Task Force recommends that women with a 5-year breast cancer risk ≥3% consider chemoprevention for breast cancer. More tha...
Main Authors: | Elad Ziv, Jeffrey A Tice, Brian Sprague, Celine M Vachon, Steven R Cummings, Karla Kerlikowske |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5249071?pdf=render |
Similar Items
-
Chemoprevention of breast cancer
by: Anna Janiak, et al.
Published: (2022-12-01) -
Breast cancer chemoprevention
by: Ivana Sestak, et al.
Published: (2011-12-01) -
Automated volumetric breast density measures: differential change between breasts in women with and without breast cancer
by: Kathleen R. Brandt, et al.
Published: (2019-10-01) -
Breast density knowledge and willingness to delay treatment for pre-operative breast cancer imaging among women with a personal history of breast cancer
by: Rebecca E. Smith, et al.
Published: (2024-04-01) -
Chemoprevention of Breast Cancer by Dietary Polyphenols
by: Maria-Magdalena Mocanu, et al.
Published: (2015-12-01)